Founded in 2008, Selecta Biosciences is leveraging its ImmTOR® platform to bring hope to the over 24 million Americans suffering from autoimmune disease daily.  ImmTOR and ImmTOR-IL (our next generation immunotherapy platform) have the potential to restore the body’s natural self-tolerance in autoimmune diseases, amplify the efficacy of biologic therapies and unlock the true potential of life-saving gene therapies. To support our ambitious pursuits, the Scientist, Translational Biology and Bioanalytical will participate on project teams to define and execute bioanalytical and biomarker strategies using LC/MS and other technical platforms. They will contribute to the expansion of the bioanalytical assay portfolio to align with multiple preclinical and clinical program n